Nanoplatform developed with three molecular imaging modalities for tumor diagnosis

Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment. With proven effectiveness in mice, the JANUS hybrid nanoplatform developed by a team of researchers from the Complutense University of Madrid (UCM) incorporates three types of molecular medical imaging to locate and diagnose solid tumours, thereby increasing the sensitivity, resolution and specificity of these tests.